1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Long-term outcome of pT1a–b, cN0 breast cancer without axillary dissection or staging : a prospective observational study of 1543 women
- 2013
- A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial.
- Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study
- 2007
- Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - Results from the Swedish randomised trial.
- 2005
-
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
Svensson Månsson, Sofie LU ; Jirström, Karin LU ; Rydén, Lisa LU
; Roos, G
; Emdin, S
; Ostrowski, M
and Landberg, Göran
LU
(2005)
In Oncogene
24(27).
p.4370-4379
Mark
- Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival
- 2004
-
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.
Stendahl, Maria LU ; Kronblad, Åsa LU ; Rydén, Lisa LU
; Emdin, S
; Bengtsson, N O
and Landberg, Göran
LU
(2004)
In British Journal of Cancer
90(10).
p.1942-1948
Mark
- 2003
- Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer